Join
Live feed
·
INSIDERFilingvia Quantisnow
BioNexus Gene Lab Corp logo

Director Low Jook Yuen was granted 16,129 shares, increasing direct ownership by 1,279% to 17,390 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BGLC (BioNexus Gene Lab Corp) and more on Quantisnow.